Andy Stergachis

Adjunct Professor, Epidemiology
Professor, Pharmacy
Professor, Global Health
Adjunct Professor, Health Metrics Sciences
Adjunct Professor, Health Systems and Population Health
Associate Dean, School of Pharmacy



PhD Pharmacy, University of Minnesota, 1979
MS Pharmacy, University of Minnesota, 1976
BPharm Pharmacy, Washington State University, 1975



Office H-362B, Health Sciences Building
Box 357631

Research Interests

Dr. Stergachis' research focus is pharmacoepidemiology, global drugs and vaccine safety, pharmaceutical outcomes research, and public health systems research. He directed a pharmacovigilance pregnancy registry study on the safety of first trimester antimalarials conducted in three sub-Saharan African countries. He is one of very few pharmacists ever elected to the National Academy of Medicine. His research has been supported, in part, by the Bill and Melinda Gates Foundation, USAID, the Barr Foundation, the Partnership for Quality Medical Donations, and USP. He is a Fellow of the International Society for Pharmacoepidemiology, Chair of the Expert Panel to Review Surveillance and Screening Technologies for the Quality Assurance of Medicines for United States Pharmacopeia, Chair of the Low-dose Primaquine Safety Study Group for the WorldWide Antimalarial Resistance Network and member of the Access and Product Management Advisory Committee for Medicines for Malaria Venture. He has conducted pharmacovigilance trainings and related pharmaceutical systems strengthening activities in numerous low- and middle-income countries (e.g., Namibia, Vietnam, Rwanda, Ethiopia, Zimbabwe, China, India, Kenya, Bangladesh, Eritrea, Philippines, Uganda, and Ukraine). Through his affiliation with the Northwest Center for Public Health Practice, he also works on workforce development and research in emergency preparedness with the public health community.

Recent Publications (PubMed)

Data collection systems for active safety surveillance of vaccines during pregnancy in low- and middle-income countries: developing and piloting an assessment tool (VPASS).
(2023 Mar 13)
BMC Pregnancy Childbirth 23(1): 172
Belizán M, Rodriguez Cairoli F, Mazzoni A, Goucher E, Zaraa S, Matthews S, Pingray V, Stergachis A, Xiong X, Berrueta M, Buekens P

Online HIV prophylaxis delivery: Protocol for the ePrEP Kenya pilot study.
Front Public Health 11(): 1054559
Kiptinness C, Naik P, Thuo N, Malen RC, Dettinger JC, Pintye J, Rafferty M, Jomo E, Nyamasyo N, Wood T, Isabelli P, Morris S, Hattery D, Stergachis A, Were D, Sharma M, Ngure K, Mugambi ML, Ortblad KF

Barriers to and strategies for early implementation of pharmacy-delivered HIV PrEP services in Kenya: An analysis of routine data.
Front Reprod Health 5(): 1023568
Nakambale HN, Roche SD, Mogere P, Omollo V, Kuo AP, Stergachis A, Baeten JM, Bukusi E, Ngure K, Mugambi ML, Ortblad KF

Safety, immunogenicity, and effectiveness of COVID-19 vaccines for pregnant persons: A protocol for systematic review and meta analysis.
(2023 Mar 3)
Medicine (Baltimore) 102(9): e32954
Ciapponi A, Berrueta M, Ballivian J, Bardach A, Mazzoni A, Anderson S, Argento FJ, Bok K, Comandé D, Goucher E, Kampmann B, Parker EPK, Rodriguez-Cairoli F, Santa Maria V, Stergachis A, Voss G, Xiong X, Zaraa S, Munoz FM, Karron RA, Gottlieb SL, Buekens PM

Identifying and addressing challenges to antimicrobial use surveillance in the human health sector in low- and middle-income countries: experiences and lessons learned from Tanzania and Uganda.
(2023 Feb 9)
Antimicrob Resist Infect Control 12(1): 9
Kiggundu R, Lusaya E, Seni J, Waswa JP, Kakooza F, Tjipura D, Kikule K, Muiva C, Joshi MP, Stergachis A, Kitutu FE, Konduri N

Show complete publication list